Samir MD - Novartis Global Relations

N1VS34 Stock  BRL 67.05  2.21  3.41%   

Insider

Samir MD is Global Relations of Novartis AG
Phone41 61 324 1111
Webhttps://www.novartis.com

Novartis Management Efficiency

The company has return on total asset (ROA) of 0.0645 % which means that it generated a profit of $0.0645 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1093 %, meaning that it generated $0.1093 on every $100 dollars invested by stockholders. Novartis' management efficiency ratios could be used to measure how well Novartis manages its routine affairs as well as how well it operates its assets and liabilities.
Novartis AG has accumulated 22.9 B in total debt with debt to equity ratio (D/E) of 0.7, which is about average as compared to similar companies. Novartis AG has a current ratio of 0.89, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Novartis until it has trouble settling it off, either with new capital or with free cash flow. So, Novartis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Novartis AG sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Novartis to invest in growth at high rates of return. When we think about Novartis' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Donald ZakrowskiEli Lilly and
N/A
David DentonPfizer Inc
58
Nancy GrygielAmgen Inc
55
DVM DVMPfizer Inc
60
Jennifer DamicoPfizer Inc
55
Alonzo WeemsEli Lilly and
N/A
Julio NetoDimed SA Distribuidora
N/A
David MDAmgen Inc
60
Jacob NaardenEli Lilly and
38
Sergio RigonDimed SA Distribuidora
N/A
Eduardo SelvaDimed SA Distribuidora
N/A
Joo AlmeidaDimed SA Distribuidora
N/A
Amy MilesAmgen Inc
52
Anat AshkenaziEli Lilly and
51
Mikael MDPfizer Inc
65
Christopher CFAPfizer Inc
N/A
Antnio NappDimed SA Distribuidora
N/A
Martin MIBSEli Lilly and
60
Diogo RauEli Lilly and
N/A
Mike ZahigianAmgen Inc
N/A
Anat JDEli Lilly and
54
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was founded in 1895 and is headquartered in Basel, Switzerland. NOVARTIS operates under Drug ManufacturersGeneral classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 110000 people. Novartis AG (N1VS34) is traded on Sao Paulo Exchange in Brazil and employs 102,000 people.

Management Performance

Novartis AG Leadership Team

Elected by the shareholders, the Novartis' board of directors comprises two types of representatives: Novartis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Novartis. The board's role is to monitor Novartis' management team and ensure that shareholders' interests are well served. Novartis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Novartis' outside directors are responsible for providing unbiased perspectives on the board's policies.
Richard Saynor, Chief Sandoz
Steffen Lang, Pres Operations
MarieFrance Tschudin, Pres Officer
Paul Penepent, Head Accounting
Samir MD, Global Relations
Robert PharmD, Chief Officer
Klaus Moosmayer, Risk Ethics
Karen Hale, Chief Officer
Vasant Narasimhan, Chief Officer
Harry Kirsch, Chief Officer

Novartis Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Novartis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Novartis Stock

Novartis financial ratios help investors to determine whether Novartis Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novartis with respect to the benefits of owning Novartis security.